Senores Pharmaceuticals IPO Day 3 Highlights: Senores Pharmaceuticals' initial public offering (IPO) closed for subscription on Tuesday, December 24, having been subscribed 93.41 times. The ...

Senores Pharmaceuticals IPO GMP today: According to market observers, shares of the company are available at a premium of ₹285 in the grey market today.(https ...

Here is how the category-wise Senores Pharma IPO fared: Non-Institutional Investors: 96.30 times subscribed to 22,33,98,732 shares against 23,19,879 shares allocated for them Qualified Institutional ...

Senores Pharmaceuticals stock debuts on the NSE at ₹600.00, registering a robust 53.5 per cent premium against the IPO price of ₹391. The stock touched an intraday high of ₹609.65 ...

Senores Pharmaceuticals Share Price, IPO Listing Live: The company raised Rs 260.63 crore from anchor investors. (Image: Freepik) Senores Pharmaceuticals Share Price, IPO Listing Highlights: The ...

(Image: Freepik) Senores Pharmaceuticals was listed at Rs 600 on the National Stock Exchange, a premium of 53.4% to the issue price. It was listed at Rs 593.7 on BSE, a premium of 51.8% to the ...

The Ahmedabad-based Senores Pharmaceuticals, which launched its ₹582.11 crore IPO on Friday at a price band of ₹372-391, has received a robust response from all investors. The IPO ...

Senores Pharmaceuticals shares are likely to be allotted to successful bidders on December 26, following a bumper subscription of 93.41 times on the final day of bidding on Tuesday. The public ...

Senores Pharmaceuticals’ IPO is a book-built issue worth Rs 582.11 crore, comprising a fresh issue of 1.28 crore shares aggregating to Rs 500 crore and an offer-for-sale (OFS) of 0.21 crore ...

Senores Pharmaceuticals is scheduled to finalise the basis of allotment of its shares on Thursday, December 26. Bidders will get the messages, alerts or emails for debit of their funds or ...

Retail Individual Investors (RIIs) subscribed to their reserved portion 90.46 times. Established in 2017, Senores Pharmaceuticals is a research-driven company specialising in developing and ...

Senores Pharmaceuticals IPO GMP has soared to 60 percent on the final day of bidding. The issue garnered 93.41 times subscription on day 3 of the subscription. The Rs 582-crore initial share sale ...